Genetic variants modify susceptibility to leukemia in infants: A Children's Oncology Group report

Pediatric Blood and Cancer

Volumn 60, Issue 1, 2013, Pages 31-34

  Ross, Julie A ^a   Linabery, Amy M ^a   Blommer, Crystal N ^a   Langer, Erica K ^a   Spector, Logan G ^a   Hilden, Joanne M ^b   Heerema, Nyla A ^c   Radloff, Gretchen A ^d   Tower, Richard L ^e   Davies, Stella M ^d  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b CHILDREN S HOSPITAL COLORADO   (United States)

^c OHIO STATE UNIVERSITY   (United States)

^d CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^e MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

Genetic susceptibility; Infants; Leukemia

Indexed keywords

MIXED LINEAGE LEUKEMIA PROTEIN;

ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; CANCER GENETICS; CANCER RISK; CHILDHOOD LEUKEMIA; CONTROLLED STUDY; GENE LOCUS; GENE REARRANGEMENT; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HOMOZYGOSITY; HUMAN; IKZF1 GENE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; TUMOR GENE;

CHILD; GENETIC PREDISPOSITION TO DISEASE; HUMANS; IKAROS TRANSCRIPTION FACTOR; LEUKEMIA, MYELOID, ACUTE; MYELOID-LYMPHOID LEUKEMIA PROTEIN; POLYMORPHISM, SINGLE NUCLEOTIDE; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA;

EID: 84870191690     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.24131     Document Type: Article

References (31)

1. Linabery AM, Ross JA. Trends in childhood cancer incidence in the U.S. 1992-2004). Cancer 2008; 112: 416-432.
2. Borkhardt A, Wuchter C, Viehmann S, et al. Infant acute lymphoblastic leukemia-Combined cytogenetic, immunophenotypical and molecular analysis of 77 cases. Leukemia 2002; 16: 1685-1690.
3. Chen SH, Yang CP, Hung IJ, et al. Clinical features, molecular diagnosis, and treatment outcome of infants with leukemia in Taiwan. Pediatr Blood Cancer 2010; 55: 1264-1271.
4. Jansen MW, Corral L, van der Velden VH, et al. Immunobiological diversity in infant acute lymphoblastic leukemia is related to the occurrence and type of MLL gene rearrangement. Leukemia 2007; 21: 633-641.
5. Koller U, Haas OA, Ludwig WD, et al. Phenotypic and genotypic heterogeneity in infant acute leukemia. II. Acute nonlymphoblastic leukemia. Leukemia 1989; 3: 708-714.
6. Pieters R, Schrappe M, De Lorenzo P, et al. A treatment protocol for infants younger than 1 year with acute lymphoblastic leukaemia (Interfant-99): An observational study and a multicentre randomised trial. Lancet 2007; 370: 240-250.
7. Pui CH, Behm FG, Downing JR, et al. 11q23/MLL rearrangement confers a poor prognosis in infants with acute lymphoblastic leukemia. J Clin Oncol 1994; 12: 909-915.
8. Chowdhury T, Brady HJ. Insights from clinical studies into the role of the MLL gene in infant and childhood leukemia. Blood Cells Mol Dis 2008; 40: 192-199.
9. Greaves M. In utero origins of childhood leukaemia. Early Hum Dev 2005; 81: 123-129.
10. Smith MT, Wang Y, Skibola CF, et al. Low NAD(P)H:quinone oxidoreductase activity is associated with increased risk of leukemia with MLL translocations in infants and children. Blood 2002; 100: 4590-4593.
11. Wiemels JL, Smith RN, Taylor GM, et al. Methylenetetrahydrofolate reductase (MTHFR) polymorphisms, risk of molecularly defined subtypes of childhood acute leukemia. Proc Natl Acad Sci USA 2001; 98: 4004-4009.
12. Zanrosso CW, Emerenciano M, Goncalves BA, et al. N-acetyltransferase 2 polymorphisms and susceptibility to infant leukemia with maternal exposure to dipyrone during pregnancy. Cancer Epidemiol Biomarkers Prev 2010; 19: 3037-3043.
13. Papaemmanuil E, Hosking FJ, Vijayakrishnan J, et al. Loci on 7p12.2, 10q21.2 and 14q11.2 are associated with risk of childhood acute lymphoblastic leukemia. Nat Genet 2009; 41: 1006-1010.
14. Trevino LR, Yang W, French D, et al. Germline genomic variants associated with childhood acute lymphoblastic leukemia. Nat Genet 2009; 41: 1001-1005.
15. Johnson KJ, Roesler MA, Linabery AM, et al. Infant leukemia and congenital abnormalities: A Children's Oncology Group study. Pediatr Blood Cancer 2010; 55: 95-99.
16. Puumala SE, Spector LG, Wall MM, et al. Infant leukemia and parental infertility or its treatment: A Children's Oncology Group report. Hum Reprod 2010; 25: 1561-1568.
17. Boyle EB, Steinbuch M, Tekautz T, et al. Accuracy of DNA amplification from archival hematological slides for use in genetic biomarker studies. Cancer Epidemiol Biomarkers Prev 1998; 7: 1127-1131.
18. Cordell HJ, Clayton DG. Genetic association studies. Lancet 2005; 366: 1121-1131.
19. Behm FG, Raimondi SC, Frestedt JL, et al. Rearrangement of the MLL gene confers a poor prognosis in childhood acute lymphoblastic leukemia, regardless of presenting age. Blood 1996; 87: 2870-2877.
20. Nagayama J, Tomizawa D, Koh D, et al. Infants with acute lymphoblastic leukemia and a germline MLL gene are highly curable with use of chemotherapy alone: Results from the Japan Infant Leukemia Study Group. Blood 2006; 107: 4663-4665.
21. Ishii E, Kawasaki H, Isoyama K, et al. Recent advances in the treatment of infant acute myeloid leukemia. Leuk Lymphoma 2003; 44: 741-748.
22. Sam TN, Kersey JH, Linabery AM, et al. MLL gene rearrangements in infant leukemia vary with age at diagnosis and selected demographic factors: A Children's Oncology Group (COG) study. Pediatr Blood Cancer 2011; DOI: 10.1002/pbc.23274.
23. Armstrong SA, Staunton JE, Silverman LB, et al. MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemia. Nat Genet 2002; 30: 41-47.
24. Stam RW, Schneider P, Hagelstein JA, et al. Gene expression profiling-based dissection of MLL translocated and MLL germline acute lymphoblastic leukemia in infants. Blood 2010; 115: 2835-2844.
25. Zangrando A, Dell'orto MC, Te Kronnie G, et al. MLL rearrangements in pediatric acute lymphoblastic and myeloblastic leukemias: MLL specific and lineage specific signatures. BMC Med Genomics 2009; 2: 36.
26. Kohlmann A, Schoch C, Dugas M, et al. New insights into MLL gene rearranged acute leukemias using gene expression profiling: Shared pathways, lineage commitment, and partner genes. Leukemia 2005; 19: 953-964.
27. John LB, Ward AC. The Ikaros gene family: Transcriptional regulators of hematopoiesis and immunity. Mol Immunol 2011; 48: 1272-1278.
28. Yang L, Luo Y, Wei J. Integrative genomic analyses on Ikaros and its expression related to solid cancer prognosis. Oncol Rep 2010; 24: 571-577.
29. Menendez P, Catalina P, Rodriguez R, et al. Bone marrow mesenchymal stem cells from infants with MLL-AF4+ acute leukemia harbor and express the MLL-AF4 fusion gene. J Exp Med 2009; 206: 3131-3141.
30. Sherborne AL, Houlston RS. What are genome-wide association studies telling us about B-cell tumor development? Oncotarget 2010; 1: 367-372.
31. Jensen K, Schaffer L, Olstad OK, et al. Striking decrease in the total precursor B-cell compartment during early childhood as evidenced by flow cytometry and gene expression changes. Pediatr Hematol Oncol 2010; 27: 31-45.